The American Association for the Treatment of Opioid Dependence (AATOD) was founded in 1984 as the Northeast Regional Methadone Treatment Coalition, Inc. Treatment providers joined together to support the legitimacy of methadone maintenance treatment for opioid dependence and to increase the availability of comprehensive treatment services to people in need of care.The Northeast Coalition evolved into the national organization in 1991, known originally as the American Methadone Treatment Association, Inc. (AMTA), to better coordinate the efforts of methadone treatment providers throughout the United States . When the organization went national, we expanded our goals to include organizing the treatment community throughout the United States . The Board of Directors approved our current name in 2001 to better embrace all forms of opioid pharmacotherapy. AATOD also began working more formally with our European partner (EUROPAD) in forming the World Federation for the Treatment of Opioid Dependence during a EUROPAD meeting in Ljubljana , Slovenia during July 2007. EUROPAD and AATOD jointly filed an application to the Committee on Non-Governmental Organizations (NGO) to the United Nations of Department of Economic and Social Affairs (DESA) during 2009. The World Federation received an approval for its NGO application during the first quarter of 2011, which will allow us to work with programs and governments in member nations of the UN to increase access to medication-assisted treatment for chronic opioid addiction wherever it is needed.
We remain committed to upholding the standards of quality comprehensive treatment first developed by Drs. Marie Nyswander and Vincent Dole in the mid-1960’s as reflected in our Ethical Canon. The American Association for the Treatment of Opioid Dependence will continue to work with the federal agencies and state substance abuse authorities concerning opioid treatment policy and developing opioid replacement pharmacotherapies. Our organization will also continue to sponsor national opioid treatment conferences, which will convene in different regions of the country.
2011: Work with representatives from the Alliance of States with Prescription Monitoring Programs and the Brandeis PMP Center of Excellence in developing policy recommendations for OTPs to gain access to PMP databases without compromising federal confidentiality protections for our patients.
2010: Work with representatives at the National Development and Research Institute (NDRI) and Brewer University in developing attitudinal surveys to understand the views of representatives in the criminal justice community in using approved medications to treat chronic opioid addiction.
2007: Formed the World Federation for the Treatment of Opioid Dependence with EUROPAD at the EUROPAD meeting in Ljubljana , Slovenia.
AATOD’s Timeline (1984 to the present)